167 related articles for article (PubMed ID: 31678194)
21. Structural determinants of the capacity of heparin to inhibit collagen synthesis in 21-day fetal rat calvariae.
Hurley MM; Kream BE; Raisz LG
J Bone Miner Res; 1990 Nov; 5(11):1127-33. PubMed ID: 2176772
[TBL] [Abstract][Full Text] [Related]
22. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
23. [Advances in heparin structural analysis by chromatography technologies].
Ouyang Y; Yi L; Qiu L; Zhang Z
Se Pu; 2023 Feb; 41(2):107-121. PubMed ID: 36725707
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides.
Ahmed T; Ungo J; Zhou M; Campo C
J Appl Physiol (1985); 2000 May; 88(5):1721-9. PubMed ID: 10797135
[TBL] [Abstract][Full Text] [Related]
25. Low molecular weight heparins and their clinical applications.
Hao C; Sun M; Wang H; Zhang L; Wang W
Prog Mol Biol Transl Sci; 2019; 163():21-39. PubMed ID: 31030749
[TBL] [Abstract][Full Text] [Related]
26. Isolation of low-molecular-weight heparin/heparan sulfate from marine sources.
Saravanan R
Adv Food Nutr Res; 2014; 72():45-60. PubMed ID: 25081076
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic construction of a library of even- and odd-numbered heparosan oligosaccharides and their N-sulfonated derivatives.
Xi X; Zhang W; Hu L; Xu R; Wang Y; Du G; Chen J; Kang Z
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130501. PubMed ID: 38442831
[TBL] [Abstract][Full Text] [Related]
28. Oligosaccharide composition of heparin and low-molecular-weight heparins by capillary electrophoresis.
Desai UR; Wang H; Ampofo SA; Linhardt RJ
Anal Biochem; 1993 Aug; 213(1):120-7. PubMed ID: 8238864
[TBL] [Abstract][Full Text] [Related]
29. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
[TBL] [Abstract][Full Text] [Related]
30. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.
Linhardt RJ; Loganathan D; al-Hakim A; Wang HM; Walenga JM; Hoppensteadt D; Fareed J
J Med Chem; 1990 Jun; 33(6):1639-45. PubMed ID: 2160537
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling and weight determination of heparins and depolymerized heparins.
Ahsan A; Jeske W; Hoppensteadt D; Lormeau JC; Wolf H; Fareed J
J Pharm Sci; 1995 Jun; 84(6):724-7. PubMed ID: 7562412
[TBL] [Abstract][Full Text] [Related]
32. Engineered heparins as new anticoagulant drugs.
Vaidyanathan D; Williams A; Dordick JS; Koffas MAG; Linhardt RJ
Bioeng Transl Med; 2017 Mar; 2(1):17-30. PubMed ID: 28516163
[TBL] [Abstract][Full Text] [Related]
33. Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry.
Camara JE; Satterfield MB; Nelson BC
J Pharm Biomed Anal; 2007 Apr; 43(5):1706-14. PubMed ID: 17275239
[TBL] [Abstract][Full Text] [Related]
34. Profiling analysis of low molecular weight heparins by multiple heart-cutting two dimensional chromatography with quadruple time-of-flight mass spectrometry.
Ouyang Y; Zeng Y; Rong Y; Song Y; Shi L; Chen B; Yang X; Xu N; Linhardt RJ; Zhang Z
Anal Chem; 2015 Sep; 87(17):8957-63. PubMed ID: 26222954
[TBL] [Abstract][Full Text] [Related]
35. Variability of heparins and heterogeneity of low molecular weight heparins.
Bianchini P; Liverani L; Spelta F; Mascellani G; Parma B
Semin Thromb Hemost; 2007 Jul; 33(5):496-502. PubMed ID: 17629846
[TBL] [Abstract][Full Text] [Related]
36. Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.
Sun X; Guo Z; Yu M; Lin C; Sheng A; Wang Z; Linhardt RJ; Chi L
J Chromatogr A; 2017 Jan; 1479():121-128. PubMed ID: 27923477
[TBL] [Abstract][Full Text] [Related]
37. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
Mourier PA; Guichard OY; Herman F; Viskov C
Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
[TBL] [Abstract][Full Text] [Related]
38. Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation.
Xie S; Guan Y; Zhu P; Li F; Yu M; Linhardt RJ; Chi L; Jin L
Carbohydr Polym; 2018 Oct; 197():83-91. PubMed ID: 30007661
[TBL] [Abstract][Full Text] [Related]
39. New data on the pharmacology of heparin and low molecular weight heparins.
Samama MM; Bara L; Gouin-Thibault I
Drugs; 1996; 52 Suppl 7():8-14; discussion 14-5. PubMed ID: 9042555
[TBL] [Abstract][Full Text] [Related]
40. Facile chemoenzymatic synthesis of unmodified anticoagulant ultra-low molecular weight heparin.
Zhang G; Yang K; Wang L; Cheng Y; Liu C
Org Biomol Chem; 2022 Nov; 20(42):8323-8330. PubMed ID: 36239281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
